404 related articles for article (PubMed ID: 29530646)
1. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
Zhang X; Kim CY; Worthen T; Witola WH
Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
[TBL] [Abstract][Full Text] [Related]
2. Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum.
Witola WH; Zhang X; Kim CY
Int J Parasitol; 2017 Nov; 47(13):867-874. PubMed ID: 28606696
[TBL] [Abstract][Full Text] [Related]
3. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
4. Genetic Ablation of a Female-Specific Apetala 2 Transcription Factor Blocks Oocyst Shedding in Cryptosporidium parvum.
Tandel J; Walzer KA; Byerly JH; Pinkston B; Beiting DP; Striepen B
mBio; 2023 Apr; 14(2):e0326122. PubMed ID: 36786597
[TBL] [Abstract][Full Text] [Related]
5. Infectivity of Cryptosporidium parvum isolated from asymptomatic adult goats to mice and goat kids.
Noordeen F; Horadagoda NU; Faizal AC; Rajapakse RP; Razak MA; Arulkanthan A
Vet Parasitol; 2002 Jan; 103(3):217-25. PubMed ID: 11750115
[TBL] [Abstract][Full Text] [Related]
6. Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.
Sagodira S; Buzoni-Gatel D; Iochmann S; Naciri M; Bout D
Vaccine; 1999 May; 17(19):2346-55. PubMed ID: 10392616
[TBL] [Abstract][Full Text] [Related]
7. Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against
Khan SM; Bajwa MR; Lahar RY; Witola WH
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056923. PubMed ID: 37655889
[No Abstract] [Full Text] [Related]
8. Cryptosporidium parvum infection in SCID mice infected with only one oocyst: qPCR assessment of parasite replication in tissues and development of digestive cancer.
Benamrouz S; Guyot K; Gazzola S; Mouray A; Chassat T; Delaire B; Chabé M; Gosset P; Viscogliosi E; Dei-Cas E; Creusy C; Conseil V; Certad G
PLoS One; 2012; 7(12):e51232. PubMed ID: 23272093
[TBL] [Abstract][Full Text] [Related]
9. Real-time nucleic acid sequence-based amplification (NASBA) assay targeting MIC1 for detection of Cryptosporidium parvum and Cryptosporidium hominis oocysts.
Hønsvall BK; Robertson LJ
Exp Parasitol; 2017 Jan; 172():61-67. PubMed ID: 27998735
[TBL] [Abstract][Full Text] [Related]
10. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
[TBL] [Abstract][Full Text] [Related]
11. Insulinase-like Protease 1 Contributes to Macrogamont Formation in Cryptosporidium parvum.
Xu R; Feng Y; Xiao L; Sibley LD
mBio; 2021 Mar; 12(2):. PubMed ID: 33688009
[TBL] [Abstract][Full Text] [Related]
12. Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test.
Hong-Xuan H; Lei C; Cheng-Min W; Kai Z; Yi T; Xi-Ming Q; Ming-Xing D
J Nanosci Nanotechnol; 2005 Aug; 5(8):1292-6. PubMed ID: 16193995
[TBL] [Abstract][Full Text] [Related]
13. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
Surl CG; Kim HC
J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
[TBL] [Abstract][Full Text] [Related]
14. A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum.
Choudhary HH; Nava MG; Gartlan BE; Rose S; Vinayak S
mBio; 2020 Aug; 11(4):. PubMed ID: 32843543
[No Abstract] [Full Text] [Related]
15. Efficacy of halofuginone lactate against experimental cryptosporidiosis in goat neonates.
Petermann J; Paraud C; Pors I; Chartier C
Vet Parasitol; 2014 May; 202(3-4):326-9. PubMed ID: 24636788
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
17. Greater intensity and frequency of Cryptosporidium and Giardia oocyst shedding beyond the neonatal period is associated with reductions in growth, carcase weight and dressing efficiency in sheep.
Jacobson C; Williams A; Yang R; Ryan U; Carmichael I; Campbell AJ; Gardner GE
Vet Parasitol; 2016 Sep; 228():42-51. PubMed ID: 27692329
[TBL] [Abstract][Full Text] [Related]
18. Development and application of an improved semiquantitative technique for detecting low-level Cryptosporidium parvum infections in mouse tissue using polymerase chain reaction.
Jenkins MC; Trout J; Fayer R
J Parasitol; 1998 Feb; 84(1):182-6. PubMed ID: 9488364
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis of pig intestinal cell monolayers infected with Cryptosporidium parvum asexual stages.
Mirhashemi ME; Noubary F; Chapman-Bonofiglio S; Tzipori S; Huggins GS; Widmer G
Parasit Vectors; 2018 Mar; 11(1):176. PubMed ID: 29530089
[TBL] [Abstract][Full Text] [Related]
20. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
Hikosaka K; Satoh M; Koyama Y; Nakai Y
Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
